Research Radboud biobank News Biobank Pilot Broad Consent at the Gate

25 February 2020

The Blue Diamond Gallery

In line with the NFU initiative “Broad Consent at the Gate” (Breed Consent aan de Poort), the Radboud Biobank is currently conducting a feasibility study examining consent procedures for the use of residual material for scientific research. Residual material encompasses biomaterials leftover from standard clinical procedures, clinical imaging and medical data. The specific aim of this study is to evaluate the impact of implementing an active consent procedure (i.e. opt-in consent, which requires explicit consent) in place of the passive consent procedure currently used in the Radboudumc (i.e. opt-out consent, which requires explicit objection). Importantly, this study does not override the consent status of previously established research studies.
As of January 13, 2020, each new patient registering for the first time at the Radboudumc is actively asked for consent to use his/her residual biomaterial, clinical imaging and medical data for scientific research. To date, there has been no major organizational obstacles in the implementation of this new consent procedure. However, its impact on available material and data is still under evaluation. In addition to quantitative analyses, qualitative research exploring underlying motivations of patients who consent or do not consent to the use of their material and data will also be performed. This feasibility study will be further expanded to assess the impact of the new consent procedure on vulnerable patient groups, i.e. children (<16 years old), acute care patients, and incapacitated patients.   
For further information, please visit our website, “Use of medical data and leftover biomaterial”  (available in Dutch only), or contact Dr. Jennifer Lutomski, project leader, at Jennifer.Lutomski@radboudumc.nl.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


National Biobanks & Collections day

19 October 2023

The Health-RI Biobanks & Collections workgroup proudly announces the first National Biobanks & Collections Day. The meeting will take place on November 9 in Amsterdam.

read more

Quality certificate for the PBMC isolation method and cfDNA extraction method

8 August 2023

Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program; an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods.

read more

TETRO-trial

30 March 2023

The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.

read more

Archipelago

30 March 2023

Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.

read more

Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard

30 March 2023

In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.

read more

Health-RI receives definitive follow-up funding from the National Growth Fund

30 March 2023

The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.

read more